Detalhe da pesquisa
1.
Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancer.
Future Oncol
; 18(13): 1535-1544, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35147043
2.
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
Am Heart J
; 188: 73-81, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577683
3.
Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.
Am J Kidney Dis
; 63(5): 753-60, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24369751
4.
Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy.
Drugs Real World Outcomes
; 2024 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38896198
5.
Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States.
Am Heart J
; 166(1): 150-6, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816034
6.
Burden of peripheral arterial disease in Europe and the United States: a patient survey.
Health Qual Life Outcomes
; 11: 175, 2013 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24148832
7.
Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens.
Drugs Real World Outcomes
; 10(4): 531-544, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659039
8.
Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study.
BMC Endocr Disord
; 11: 17, 2011 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22035104
9.
Healthcare Resource Use and Cost: The Impact of Adopting an Abuse-Deterrent Formulation of Extended Release Morphine.
Clinicoecon Outcomes Res
; 12: 35-44, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32021338
10.
Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization.
Am Health Drug Benefits
; 13(1): 21-31, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165996
11.
Assessment of Work Loss Associated With Prescription-Related Opioid Use Disorder: A Retrospective Analysis of Claims Data.
J Occup Environ Med
; 62(3): 217-222, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134845
12.
Safe Opioid Storage and Disposal: A Survey of Patient Beliefs and Practices.
J Pain Res
; 13: 987-995, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32494187
13.
Health Care Utilization and Costs Associated with Nausea and Vomiting in Patients Receiving Oral Immediate-Release Opioids for Outpatient Acute Pain Management.
Pain Ther
; 5(2): 215-226, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27704485
14.
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.
J Med Econ
; 18(11): 898-908, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26086414
15.
One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel.
Am J Cardiovasc Drugs
; 15(5): 337-50, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26359016
16.
A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
Curr Med Res Opin
; 30(12): 2415-22, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25222764
17.
Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
Vasc Health Risk Manag
; 10: 237-46, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24851051
18.
LDL-C levels in US patients at high cardiovascular risk receiving rosuvastatin monotherapy.
Clin Ther
; 36(5): 792-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24768187
19.
Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database.
Curr Med Res Opin
; 30(4): 655-65, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24495126
20.
Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
Am J Cardiol
; 112(3): 373-9, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23642513